Copyright
©The Author(s) 2025.
World J Methodol. Jun 20, 2025; 15(2): 101458
Published online Jun 20, 2025. doi: 10.5662/wjm.v15.i2.101458
Published online Jun 20, 2025. doi: 10.5662/wjm.v15.i2.101458
Table 3 Merits and de-merits of bone marrow from various anatomical locations
Anatomical site | Merits | Demerits |
Anterior superior iliac spine | Ease of access: Superficially located and easy to palpate, facilitating quicker and less invasive procedures | Lower cell purity: Increased risk of blood dilution due to fatty tissue, potentially reducing MSC concentration |
Adequate yield: Provides a good volume of aspirate with acceptable TNC and CFU-f yields | Variable CFU-f yield: Typically lower CFU-f counts compared to the posterior superior iliac spine, which may affect the therapeutic potential of the aspirate | |
Lower complication rate: Reduced risk of neurovascular injury and other complications when performed with proper technique | Patient discomfort: Proximity to muscle attachments can cause discomfort during and after the procedure | |
High culture success rate: High success rate in MSC culture, indicating reliable cell viability and expansion potential | Postoperative pain: Potential for significant postoperative pain and hematoma formation | |
Posterior superior iliac spine | High cell yield: Provides a high concentration of TNCs and CFU-fs, making it the preferred site for harvesting high-quality aspirates | Increased technical difficulty: Less accessible, particularly in patients with high BMI or anatomical variations, requiring more complex positioning and technique |
Reduced blood dilution: Lower fatty infiltration results in higher cell purity and reduced blood contamination | Higher risk of complications: Proximity to the sacroiliac joint and gluteal neurovascular bundle increases the risk of neurovascular injury | |
Consistency in results: Yields consistent results with less variability in cell counts across different patients | Patient discomfort: A deeper location and the need to traverse more tissue can cause significant post-procedural pain | |
Gold standard for MSC yield: Considered the gold standard for bone marrow harvesting due to its high MSC yield and well-established protocols | Donor-site morbidity: Associated with significant morbidity, including pain, hematoma, and nerve injury, which may deter its use in certain populations | |
Proximal tibia | Convenience in certain surgeries: Proximity to the knee joint makes it convenient during knee-related surgeries, reducing procedure time | Lower MSC concentration: Typically provides a lower concentration of MSCs compared to the iliac crest, which may limit its effectiveness in regenerative therapies |
Adequate cell yield in some cases: Can produce a reasonable volume of aspirate, especially when large volumes are needed | Greater variability in yield: High variability in cell yield depending on factors such as patient age, BMI, and bone density, leading to inconsistent results | |
Reduced risk of major complications: Stable site with a lower risk of major complications like neurovascular injury, making it a safer choice in some contexts | Difficulty in aspiration technique: Requires careful technique to avoid complications such as cortical bone fracture, particularly in osteoporotic patients | |
Integrated into knee surgeries: Easily integrated into knee surgeries like TKA, adding minimal additional risk and reducing invasiveness | Lower culture success rate: MSC culture success rate is lower compared to the iliac crest, which may limit its utility in certain therapeutic applications | |
Proximal humerus | Convenience in shoulder surgeries: Located within the surgical field during shoulder procedures, reducing the need for an additional surgical site | Limited data: While promising, there is limited data compared to the iliac crest, and long-term outcomes need further study |
High MSC yield: Can yield a comparable number of progenitor cells to the iliac crest, making it a viable alternative for bone marrow aspirate concentrate preparation | Variability with age: Potential variability in MSC yield with age, although studies suggest this site may still be reliable across different age groups | |
Reduced morbidity: Less invasive compared to iliac crest harvesting, with a lower risk of complications and patient discomfort | Not standard practice: Not as widely used or studied as the iliac crest, leading to less familiarity and potentially greater variability in outcomes | |
Distal femur | Ease of access during knee surgeries: Easily accessible during knee surgeries such as TKA, reducing the need for additional procedures | Lower MSC concentration: Significantly lower MSC concentration compared to the iliac crest, potentially limiting its effectiveness in high-demand applications |
Lower postoperative complications: Reduced invasiveness with potentially fewer postoperative complications, particularly in patients with previous pelvic surgeries | Lower culture success rate: The culture success rate for MSCs is lower than that of the iliac crest, which may affect the feasibility of its use in large-scale therapeutic applications | |
Potential for integration into existing surgeries: Can be seamlessly integrated into existing knee procedures, adding minimal risk and enhancing therapeutic options | Inconsistent yield: Variability in cell yield can lead to inconsistent outcomes, which may affect the reliability of the site for routine use in MSC harvesting | |
Acetabulum | Dual-purpose during hip surgeries: Accessible during hip surgeries, allowing simultaneous bone marrow harvesting without additional surgical risks | Limited to hip procedures: Primarily applicable in the context of hip surgeries, limiting its broader use in other orthopedic applications such as knee OA |
Comparable yield to iliac crest: Studies suggest a comparable progenitor cell yield to the iliac crest, making it a feasible alternative in certain contexts | Not a primary choice for knee OA: While effective for hip procedures, its role in knee OA treatment is more indirect and not commonly pursued as a first choice |
- Citation: Nallakumarasamy A, Shrivastava S, Rangarajan RV, Jeyaraman N, Devadas AG, Ramasubramanian S, Jeyaraman M. Optimizing bone marrow harvesting sites for enhanced mesenchymal stem cell yield and efficacy in knee osteoarthritis treatment. World J Methodol 2025; 15(2): 101458
- URL: https://www.wjgnet.com/2222-0682/full/v15/i2/101458.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i2.101458